Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | QDEL QuidelOrtho Corporation | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $10.54 -0.6% | $16.31 +6.3% |
| StockIQ Score | 39F Weak Risk: High | 42D Weak Risk: Medium |
| Technical | 19F | 36F |
| Fundamental | 26F | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 38F | 38F |
| News | 68B- | 50C- |
| Quality | 42D | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
QuidelOrtho (QDEL) outperforms Ascentage Pharma (AAPG) in growth, scoring 68 versus 50, indicating stronger anticipated revenue or earnings expansion. However, AAPG has a slightly better investor score (42 vs. 39) and a higher technical score (36 vs. 19), suggesting more favorable short-term trading conditions. Both carry a "WEAK" rating, but QDEL’s growth potential is its clear advantage.
